About Koen Clymans
Strategic technology advisor in industrial biotechnology and advanced manufacturing, supporting boards, investors and founders through complex scale-up and capital inflection cycles.
Industrial foundation and leadership trajectory
Koen Clymans brings over two decades of experience in industrial biotechnology, process engineering and industrial scale-up governance. Early leadership roles at DSM and Tate & Lyle established a foundation in large-scale industrial operations, disciplined capital deployment and technology-driven growth.
His executive development included business education at INSEAD, reinforcing a structured approach to capital allocation, governance and decision-making within complex industrial environments.
Since transitioning into advisory and executive scale-up roles, he has supported high-growth biosolutions ventures navigating the transition from pilot to industrial production, aligning scientific ambition with operational robustness and long-term capital logic.
- Senior leadership roles at DSM and Tate & Lyle
- Executive oversight of industrial scale-up programmes
- Capital-aligned technology and process architecture
- Board and steering committee advisory mandates
Approach to industrial scale-up
Industrial scale-up is rarely constrained by science alone. It requires disciplined alignment between technology architecture, organisational capability and capital structure.
Koen’s advisory work focuses on translating scientific progress into industrial systems capable of delivering long-term operational performance. This involves rigorous evaluation of scale risks, capital deployment and governance clarity during periods of rapid organisational growth.
Board and investor advisory
As ventures move from innovation to industrial deployment, board-level oversight of technology scalability and capital exposure becomes decisive. Koen supports boards and investors with independent technical perspective on scale feasibility, capital deployment sequencing and execution discipline.
Engagements are selective and focused on industrial biosolutions and advanced manufacturing platforms with long-term scale ambition and capital discipline.
Core areas of expertise
Koen has worked across multiple biological production platforms including yeast fermentation, filamentous fungi processes and mammalian cell cultivation systems, supporting scale-up from pilot environments to industrial production.
Primary areas of expertise include:
- Industrial biotechnology scale-up architecture across microbial and cell-based systems
- Techno-Economic Analysis (TEA) for industrial biotechnology scale-up
- Process engineering and manufacturing strategy
- Capital-intensive project leadership
- Governance of technology risk at board and investor level
- Technology roadmap alignment with investment strategy
- Executive scale-up leadership and fractional CTO mandates